LYB vs STRO
LyondellBasell Industries NV (LYB) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the LYB and STRO stock pages for the full models.
Not investment advice.